hers vs noom for glp 1 offers cut-price compounded GLP-1 drug obesity The Noom Engagement Report: New

Ard, J., Fitch, A., Fruh, S

Overview of GLP-1 Receptor Agonists for Weight Loss Receptor agonists that target the GLP-1 pathway play a crucial role in managing obesity and type 2 diabetes

If you have concerns about the administration process, refer to the instructions that came with the medication or consult with your healthcare provider

When speaking to your GP or specialist, consider raising the following: Your weight management goals and what evidence-based options are available Any supplements or compounds you are currently using or considering Symptoms you may already be experiencing that could indicate metabolic or hormonal imbalance Your eligibility for NHS-funded obesity treatments , including approved GLP-1 therapies Healthcare professionals are not there to judge but to help you make informed, safe decisions

It is important to clarify that these patches do not contain GLP-1 agonist drugs such as Semaglutide or Tirzepatide